Effect of Propofol and Sevoflurane on Lactate During Anesthesia for Pediatric Heart Catheterisation (PRISCATHLAB)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Propofol is routinely used for general anesthesia during pediatric heart catheterisation. Propofol infusion syndrome (PRIS) is a rare, but often fatal complication mainly defined by bradycardia with progress to asystolia during propofol infusion. Metabolic acidosis is regarded as an early warning sign of PRIS. In this study the effect of propofol and sevoflurane on serum base excess, pH and lactate are examined during pediatric heart catheterisation.
| Condition | Intervention |
|---|---|
|
Metabolic Acidosis |
Drug: Propofol |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Pharmacodynamics Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Screening |
| Official Title: | Effect of Propofol and Sevoflurane on Base Excess, pH and Lactate in Pediatric Heart Catheterisation |
- Serum Lactate [ Time Frame: 4 hours ] [ Designated as safety issue: No ]Serum lactate is measured during application of propofol and sevoflurane to examine the effect on metabolic acidosis.
- pH and base excess [ Time Frame: Hours ] [ Designated as safety issue: No ]pH and base excess are measured during application of Propofol and Sevoflurane to examine the effect on acid-base balance
| Enrollment: | 40 |
| Study Start Date: | June 2009 |
| Study Completion Date: | August 2010 |
| Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Propofol
Anesthesia is changed from Sevoflurane to Propofol after obtaining baseline blood gas analysis from the heart catheterisation sheath.
|
Drug: Propofol
Anesthesia is switched from sevoflurane to propofol after obtaining a baseline blood gas analysis.
Other Name: Disoprivan
|
|
No Intervention: Sevoflurane
Sevoflurane anesthesia is maintained after obtaining a baseline blood gas analysis.
|
Detailed Description:
In this prospective randomised study 40 children are anesthetised for pediatric heart catheterisation with propofol (N = 22) or sevoflurane (N = 18) with ethic committee approval. Base excess, pH and lactate were measured by blood gas analysis at the beginning, during and at the end of the procedure. Changes relative to baseline were analysed by paired t-Test with correction for multiple testing. The study was powered to detect a difference of 1.5 mmol/l for base excess and lactate.
Eligibility| Ages Eligible for Study: | up to 12 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Indication for heart catheterization under general anesthesia
Exclusion Criteria:
- Participation in another study
- Preexisting metabolic acidosis
- Contraindication against Propofol
Contacts and Locations| Germany | |
| University Hospital Schleswig-Holstein, Campus Kiel | |
| Kiel, Schleswig-Holstein, Germany, 24105 | |
| Study Director: | Berthold Bein, Prof. Dr. | University Hospital Schleswig-Holstein, Campus Kiel |
More Information
No publications provided
| Responsible Party: | Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel |
| ClinicalTrials.gov Identifier: | NCT01293266 History of Changes |
| Other Study ID Numbers: | Fudickar2 |
| Study First Received: | February 9, 2011 |
| Last Updated: | March 10, 2011 |
| Health Authority: | Germany: Ethics Commission |
Keywords provided by University of Schleswig-Holstein:
|
Propofol Metabolic Acidosis Pediatric Cardiology Anesthesia |
Additional relevant MeSH terms:
|
Acidosis Acid-Base Imbalance Metabolic Diseases Anesthetics Propofol Sevoflurane Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions |
Central Nervous System Agents Therapeutic Uses Anesthetics, Intravenous Anesthetics, General Hypnotics and Sedatives Platelet Aggregation Inhibitors Hematologic Agents Anesthetics, Inhalation |
ClinicalTrials.gov processed this record on May 23, 2013